Learn
-
Biopreservation Benchmarking Results from OHRI’s Biotherapeutics Manufacturing Center
Highlights from the ongoing collaboration between OHRI's BMC and CryoStasis presented at the 2024 Till & McCullouch Meeting -
Kidney Transplant Results presented at the American Society of Nephrology Annual Meeting in Philadelphia
CryoStasis & UHN deliver compelling kidney transplant results for subzero unfrozen preservation technology -
-
Quality Management System - Management Responsibility
Describes the interdependency of corporate strategy and QMS -
Why Quality Management Systems are critical for Medical Device companies
This article describes the relevance of a QMS for leading medical device companies -
CryoStasis Technology Explainer
CryoStasis technology is based on the belief that stored biological material is best preserved by reducing its metabolic rate and ischemic interval. -
Olga’s Central Hypothesis
This hypothesis begs the question: How cold can something be stored in stable liquid state without freezing? The freezing point of a substance depends on its water content. An orange will not freeze until its temperature is below -2.1°C. -
Model Systems for the Storage of Mammalian Cells, Tissues, and Organs CryoStasis Inc.
During the period from 2006 until 2018 the authors undertook a series to studies to determine the benefits of cold shock inhibitors, cryoprotectants, compounds that promote desiccation resistance, and increase membrane plasticity during cooling. -
Cool idea: Ottawa biotech firm’s cell-chilling technology lures major investors, big-name CEO
CryoStasis announced earlier this month that Keith Millar has joined the fledgling firm as president and chief executive. -
We’re on a mission to enable lifesaving research and improve patient outcomes around the world.
Join Us